2-amino-5-phosphonovalerate has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, S | 1 |
| Ma, Y | 1 |
| Dunn, AR | 1 |
| Bradner, JM | 1 |
| Scimemi, A | 1 |
| Miller, GW | 1 |
| Traynelis, SF | 1 |
| Wichmann, T | 1 |
| Kupsch, A | 1 |
| Löschmann, PA | 1 |
| Sauer, H | 1 |
| Arnold, G | 1 |
| Renner, P | 1 |
| Pufal, D | 1 |
| Burg, M | 1 |
| Wachtel, H | 1 |
| ten Bruggencate, G | 1 |
| Oertel, WH | 1 |
2 other studies available for 2-amino-5-phosphonovalerate and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2-Amino-5-phosphonovalerate; Action Potentials; Animal | 2018 |
Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal | 1992 |